Nkarta, Inc. (NKTX) stock
NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.25+0.04 (+3.31%)
Close on Nov 17, 2026Market cap $89.53MP/E –Yield 0.00%
Nkarta total assets
Total assets on the balance sheet at the end of each period.
Nkarta's total assets was $337.65M at Jun 30, 2026. For fiscal 2025 it was $404.21M, down 19.4% from the year before. The highest annual figure on record is $501.20M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $404.21M | -19.4% |
| FY2024 | Dec 31, 2024 | $501.20M | +32.3% |
| FY2023 | Dec 31, 2023 | $378.89M | -19.9% |
| FY2022 | Dec 31, 2022 | $472.94M | +72.7% |
| FY2021 | Dec 31, 2021 | $273.90M | -18.9% |
| FY2020 | Dec 31, 2020 | $337.65M | +597.5% |
| FY2019 | Dec 31, 2019 | $48.41M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $337.65M | -24.7% |
| Q1 FY2026 | Mar 31, 2026 | $372.07M | -20.9% |
| Q4 FY2025 | Dec 31, 2025 | $404.21M | -19.4% |
| Q3 FY2025 | Sep 30, 2025 | $427.24M | -19.7% |
| Q2 FY2025 | Jun 30, 2025 | $448.31M | -19.1% |
| Q1 FY2025 | Mar 31, 2025 | $470.61M | -18.4% |
| Q4 FY2024 | Dec 31, 2024 | $501.20M | +32.3% |
| Q3 FY2024 | Sep 30, 2024 | $532.03M | +31.1% |
| Q2 FY2024 | Jun 30, 2024 | $554.09M | +29.1% |
| Q1 FY2024 | Mar 31, 2024 | $576.94M | +25.9% |
| Q4 FY2023 | Dec 31, 2023 | $378.89M | -19.9% |
| Q3 FY2023 | Sep 30, 2023 | $405.86M | -19.4% |
| Q2 FY2023 | Jun 30, 2023 | $429.04M | -14.8% |
| Q1 FY2023 | Mar 31, 2023 | $458.17M | +49.6% |
| Q4 FY2022 | Dec 31, 2022 | $472.94M | +72.7% |
| Q3 FY2022 | Sep 30, 2022 | $503.80M | +72.3% |
| Q2 FY2022 | Jun 30, 2022 | $503.64M | +62.9% |
| Q1 FY2022 | Mar 31, 2022 | $306.30M | -6.0% |
| Q4 FY2021 | Dec 31, 2021 | $273.90M | -18.9% |
| Q3 FY2021 | Sep 30, 2021 | $292.47M | -17.0% |
| Q2 FY2021 | Jun 30, 2021 | $309.11M | +608.7% |
| Q1 FY2021 | Mar 31, 2021 | $325.69M | +572.8% |
| Q4 FY2020 | Dec 31, 2020 | $337.65M | – |
| Q3 FY2020 | Sep 30, 2020 | $352.30M | – |
| Q2 FY2020 | Jun 30, 2020 | $43.62M | – |
| Q4 FY2019 | Dec 31, 2019 | $48.41M | – |
See a number that looks wrong?